摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole | 1424375-08-5

中文名称
——
中文别名
——
英文名称
5-Bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole
英文别名
5-bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole
5-Bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole化学式
CAS
1424375-08-5
化学式
C16H9BrN4O4S
mdl
——
分子量
433.242
InChiKey
OOKIMHLMHGNBDK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    135
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-Bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole[(4-甲氧苯基)次甲基]氮烷氧化三乙胺1,3-二-叔丁基咪唑氯化物 作用下, 以 二氯甲烷 为溶剂, 反应 0.53h, 以92%的产率得到5-[[5-Bromo-2-(2,4-dinitrophenyl)sulfanylbenzimidazol-1-yl]methyl]-3-(4-methoxyphenyl)-1,2-oxazole
    参考文献:
    名称:
    Regioselective synthesis of isoxazole–mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies
    摘要:
    Regioselective synthesis of isoxazole-mercaptobenzimidazole hybrids and their efficiency in in vivo analgesic and anti-inflammatory activity was described. A comparison of structure-activity relationship for there compounds was also emphasized. (c) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.12.101
  • 作为产物:
    描述:
    5-溴-1,3-二氢-2H-苯并咪唑-2-硫酮potassium carbonate 、 potassium hydroxide 作用下, 以 乙醇丙酮甲苯 为溶剂, 反应 8.0h, 生成 5-Bromo-2-(2,4-dinitrophenyl)sulfanyl-1-prop-2-ynylbenzimidazole
    参考文献:
    名称:
    Regioselective synthesis of isoxazole–mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies
    摘要:
    Regioselective synthesis of isoxazole-mercaptobenzimidazole hybrids and their efficiency in in vivo analgesic and anti-inflammatory activity was described. A comparison of structure-activity relationship for there compounds was also emphasized. (c) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.12.101
点击查看最新优质反应信息

文献信息

  • Regioselective synthesis of some new 1,4-disubstituted sulfonyl-1,2,3-triazoles and their antibacterial activity studies
    作者:Narasimha Swamy Thirukovela、Shravankumar Kankala、Ranjith Kumar Kankala、Suresh Paidakula、Mohan Rao Gangula、Chandra Sekhar Vasam、Ravinder Vadde
    DOI:10.1007/s00044-017-1926-6
    日期:2017.9
    Some new 1,4-disubstituted-sulfonyl-1,2,3-triazoles (3a–f, 5a–h, 7a–d, and 9a–e) were regioselectively synthesized in high yields by Cu(I) catalyzed 1,3-dipolar cycloaddition (DC) reaction of p-acetamidobenzenesulfonyl azide (p-ABSA) with terminal alkynes. These new triazole compounds were evaluated for in vitro antibacterial activity against a panel of Gram-positive Bacillus sphericus, Staphylococcus
    Cu(I)催化1,3以高收率选择性合成了一些新的1,4-二取代-磺酰基-1,2,3-三唑(3a – f,5a – h,7a – d和9a – e)。顺丁烯二(DC)反应p -acetamidobenzenesulfonyl叠氮化物(p -ABSA)与末端炔烃。评估了这些新的三唑化合物对一组革兰氏阳性球菌,表皮葡萄球菌和革兰氏阴性克雷伯菌肺炎,大肠杆菌的体外抗菌活性。种类。发现这些化合物中的几种具有与商业标准青霉素-G和链霉素相当的生长抑制活性。
  • Regioselective synthesis of isoxazole–mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies
    作者:Shravankumar Kankala、Ranjith Kumar Kankala、Prasad Gundepaka、Niranjan Thota、Srinivas Nerella、Mohan Rao Gangula、Hanmanthu Guguloth、Mukkanti Kagga、Ravinder Vadde、Chandra Sekhar Vasam
    DOI:10.1016/j.bmcl.2012.12.101
    日期:2013.3
    Regioselective synthesis of isoxazole-mercaptobenzimidazole hybrids and their efficiency in in vivo analgesic and anti-inflammatory activity was described. A comparison of structure-activity relationship for there compounds was also emphasized. (c) 2013 Elsevier Ltd. All rights reserved.
查看更多